% | $
Quotes you view appear here for quick access.

OncoGenex Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • dr.kuvasz dr.kuvasz Jul 23, 2009 7:48 PM Flag

    Shorted more average is 25.85 now

    Here is my summary:

    1. phase III studies of ogxi are "well powered" to succeed on the phase II results;
    2. since ogxi is actively responding to dilegence requests around their pipeline, "we expect ogxi to enter into a partnership/sale of the company in H2:09;
    3. assuming partnership, 12 month price target is $40/share;
    4. assuming $700 million market capitalization just prior to positive Phase III date at Year end 2011 (assuming 1.3 billion with positive results with 35% discount rate), then ogxi could sell itself for $750 million in cash;
    5. with 6 million shares outstanding, potential value to shareholders $125/share (plus/minus 30 per share on lack of certainty on value of company at $750 million

    I would like to disclose that this summary has been completed at the expense of the Canadian taxpayer - not in part but in whole.

    I am biting my tongue beauxminis. you have only made one prior contribution to this board before today and that was to correct endspeed's french....

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.90-0.02(-2.17%)Jul 22 3:59 PMEDT